Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis
Authors
Keywords
Galactomannan, Biomarker, Aspergillosis, Antifungal, Prognostic tool
Journal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Volume 44, Issue 2, Pages 143-151
Publisher
Springer Nature
Online
2017-02-08
DOI
10.1007/s10928-017-9509-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis
- (2016) Vidmantas Petraitis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy
- (2016) Luc J. Huurneman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints
- (2016) Laura L. Kovanda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of Amphotericin B Deoxycholate, Amphotericin B Lipid Complex, and Liposomal Amphotericin B against Aspergillus fumigatus
- (2015) Zaid Al-Nakeeb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Isavuconazole in a DynamicIn VitroModel of Invasive Pulmonary Aspergillosis
- (2015) Helen Box et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis
- (2015) Ruta Petraitiene et al. MEDICAL MYCOLOGY
- Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis
- (2015) Dionysios Neofytos et al. PLoS One
- Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in anIn VitroPharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum
- (2014) A. Elefanti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
- (2014) Michael J. Dolton et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model--authors' response
- (2014) M. Siopi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Micafungin for the treatment of invasive aspergillosis
- (2014) D.A. Enoch et al. JOURNAL OF INFECTION
- Serum and urine galactomannan testing for screening in patients with hematological malignancies
- (2014) W. Duettmann et al. MEDICAL MYCOLOGY
- Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
- (2014) Louis Yi Ann Chai et al. PLoS One
- Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
- (2014) Marcio Nucci et al. PLoS One
- Single-Dose Pharmacodynamics of Amphotericin B against Aspergillus Species in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Rafal Al-Saigh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MIC Values of Voriconazole Are Predictive of Treatment Results in Murine Infections by Aspergillus terreus Species Complex
- (2013) Valentina Salas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole resistance in Aspergillus fumigatus
- (2013) Edith Vermeulen et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Electronic Nose Technology for Detection of Invasive Pulmonary Aspergillosis in Prolonged Chemotherapy-Induced Neutropenia: a Proof-of-Principle Study
- (2013) K. de Heer et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pharmacodynamics of Itraconazole against Aspergillus fumigatus in anIn VitroModel of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration
- (2012) Zaid Al-Nakeeb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Voriconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis: Implications for In Vitro Susceptibility Breakpoints
- (2012) Adam R. Jeans et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a NewIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Joseph Meletiadis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition
- (2011) S. A. Nouer et al. CLINICAL INFECTIOUS DISEASES
- Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay
- (2011) A. M. Tortorano et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy
- (2011) Susan J. Howard et al. JOURNAL OF INFECTIOUS DISEASES
- The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1->3)- -D-Glucan, and Consequences of Delayed Antifungal Therapy
- (2010) W. W. Hope et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
- (2010) R Herbrecht et al. BONE MARROW TRANSPLANTATION
- Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
- (2010) S. Koo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)- -D-glucan detection in serum samples as an adjunct to diagnosis
- (2010) E. Mokaddas et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
- (2009) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients
- (2009) Johan Maertens et al. CANCER
- Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis
- (2008) C. R. Thornton Clinical and Vaccine Immunology
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications
- (2008) Marisa H. Miceli et al. CLINICAL INFECTIOUS DISEASES
- Liposomal amphotericin B: what is its role in 2008?
- (2008) F. Lanternier et al. CLINICAL MICROBIOLOGY AND INFECTION
- Conventional or molecular measurement ofAspergillusload
- (2008) K. V. Clemons et al. MEDICAL MYCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More